Hypereosinophilia with systemic manifestations under dupilumab and possibility of dual benralizumab and dupilumab therapy in patients with asthma and CRSwNP

J Allergy Clin Immunol Pract. 2021 Dec;9(12):4477-4479. doi: 10.1016/j.jaip.2021.07.049. Epub 2021 Aug 9.

¹ Department of Medicine V, University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center (CPC-M), LMU and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.
² Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, LMU Munich, Munich, Germany.
³ Department of Medicine V, University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center (CPC-M), LMU and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany. Electronic address: Katrin.Milger@med.uni-muenchen.de.

No abstract available

Publication types